Study reveals 1 in 15 men carry sperm mutations that could harm offspring

Mutations in sperm can cause autism spectrum disorder, congenital heart disease, and severe pediatric diseases in offspring, potentially accounting for 15% of ASD cases.
The mutations were already there, hidden for decades.
Researchers found that sperm mutations originate during fetal development and remain stable, not accumulating with paternal age.

In the quiet architecture of inheritance, researchers have discovered that roughly one in fifteen men carries sperm mutations capable of shaping the health of children not yet born — mutations that do not accumulate with age, as long assumed, but are etched into the body during fetal development itself. A team at the Rady Children's Institute and UC San Diego has developed a method sensitive enough to see what was previously invisible, finding that these hidden genetic variations may account for a meaningful share of autism spectrum disorder, congenital heart disease, and other serious pediatric conditions. The discovery reframes paternal risk not as something that grows over a lifetime, but as something present from the very beginning — fixed, silent, and now, for the first time, detectable.

  • A new genomic sequencing method has revealed that one in fifteen men silently carries sperm mutations capable of causing autism, heart defects, and severe disease in their children — a risk hiding in plain sight across generations.
  • The finding dismantles a foundational assumption in reproductive medicine: mutations in sperm do not accumulate with age like rust on metal, but appear to be set during the father's own fetal development and remain stable for decades.
  • Because these mutations appear almost exclusively in sperm — absent from blood and saliva — they evade standard genetic testing, meaning most carriers have no way of knowing their risk exists at all.
  • Researchers estimate these mosaic mutations may be responsible for roughly 15 percent of autism spectrum disorder cases, a fraction large enough to reshape how clinicians think about the origins of conditions long attributed to chance.
  • The team is now recruiting affected families and partnering with infertility clinics to determine whether these mutations pass to embryos during assisted reproduction, moving toward the possibility of routine screening before conception.

Every cell in the human body accumulates genetic damage over time — small, scattered alterations that rarely matter. But when mutations concentrate in sperm, they can pass directly to children, and what was silent in the parent becomes visible in the child.

Researchers at the Rady Children's Institute of Genomic Medicine and UC San Diego have now made that invisible process measurable. Publishing in Cell in August 2021, the team found that one in every fifteen men carries sperm mutations capable of harming his offspring. To detect them, they sequenced sperm samples hundreds of times across entire genomes, using machine learning to identify genetic changes present in only a small fraction of cells.

The findings challenge a long-held assumption. Older fathers have higher rates of children with autism, birth defects, and epilepsy — and researchers had assumed sperm mutations simply accumulated with age. But when the team compared older and younger men, they found no meaningful difference. The mutations were not growing in number over time. They were already present, believed to have originated during the father's own fetal development, then preserved for decades inside a biological sanctuary researchers call a stem cell niche.

Each ejaculate carries an average of thirty such mutations. Crucially, when researchers checked blood and saliva from the same men, those mutations were absent — confirming the changes were confined to reproductive cells and validating the detection method itself. Senior author Joseph Gleeson estimates these mutations may account for roughly fifteen percent of autism spectrum disorder cases, as well as congenital heart disease and other serious pediatric conditions.

The team is now translating these findings toward clinical use — recruiting families affected by new mutations, partnering with infertility clinics to study whether mosaic mutations pass to embryos during assisted reproduction, and working toward screening tools that could one day give prospective parents a clearer picture before conception. The mutations themselves are not new. They have traveled through families for generations, largely unseen. What has changed is the ability to finally see them.

Every cell in the human body collects genetic damage over time. Most of it goes unnoticed—a few altered DNA sequences here and there, scattered across billions of cells, too small a fraction to matter. But when those mutations concentrate in sperm or egg cells, they can pass directly to children, and what was silent in the parent becomes visible in the child.

Researchers at the Rady Children's Institute of Genomic Medicine and UC San Diego have now quantified something that was previously invisible: how many men carry these transmissible mutations, and how often they cause disease. The answer, published in Cell on August 12, 2021, is stark. One in every 15 men carries mutations in his sperm that could harm his offspring. The team developed a new method to detect these mutations by sequencing sperm samples hundreds of times across their entire genomes, using machine learning to spot genetic changes present in only a small fraction of cells.

The findings overturn an older assumption. For years, researchers knew that older fathers had higher rates of certain diseases in their children—autism spectrum disorder, birth defects, epilepsy. The natural conclusion was that sperm mutations accumulated with age, like rust on metal. But when the team compared sperm from older men with younger men, they found no meaningful difference in the number of detectable mutations. The mutations, it turned out, were not accumulating. They were already there. The researchers believe these mutations originated during fetal development, when the father himself was still in the womb. They then remained stable, hidden inside sperm cells, protected in what researchers call a stem cell niche—a biological sanctuary that preserves these cells and their genetic cargo across decades.

Each ejaculate contains an average of 30 mutations, the researchers found. Almost all of them appeared only in sperm; when the team checked saliva or blood samples from the same men, those mutations were absent. This confirmed the mutations were confined to reproductive cells and validated the detection method itself. The discovery matters because it means a man's risk of passing on a harmful mutation is essentially fixed from birth. Age does not increase it. But it also means that risk exists whether or not a man knows it, whether or not disease runs in his family.

The potential impact on public health is substantial. Joseph Gleeson, the senior author and director of neuroscience research at the Rady Children's Institute, estimates these mutations may account for roughly 15 percent of autism spectrum disorder cases, as well as congenital heart disease and other severe pediatric diseases. That is a significant fraction of conditions that have long been attributed to other causes or simply to chance.

The research team is now working to translate these findings into clinical practice. They are recruiting families where a child has been diagnosed with a disease caused by a new mutation, asking fathers to provide sperm samples so researchers can test whether the mutation is present in the broader sperm population. They are also partnering with infertility clinics to study whether these mosaic mutations are passed to embryos during assisted reproduction, with the eventual goal of screening and prevention. The next phase of research will focus on understanding why these mutations arise in the first place, and whether environmental exposures during fetal development might explain variations between individuals.

For now, the study has established a baseline: one in 15 men. That number will likely drive new conversations between doctors and patients planning families, and new questions about whether screening should become routine. The mutations are not new. They have been traveling through families for generations, mostly undetected. What is new is the ability to see them.

We think that these mutations contribute a substantial burden on human health, potentially causing 15 percent of ASD cases, congenital heart disease and severe pediatric diseases.
— Joseph Gleeson, Senior Author and Director of Neuroscience Research at the Rady Children's Institute
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

So these mutations exist in one in 15 men, but most of them never know it. How does something that significant stay hidden?

Model

Because the mutations are confined to sperm cells. A man's blood and saliva are clean. He could live his whole life with no sign of it. The only way it becomes visible is if he has a child and that child develops a disease.

Inventor

But the researchers say these mutations probably started when the father was a fetus. That's decades before he ever produces sperm.

Model

Right. The mutations arise early, during fetal development, and then they get locked into place. The sperm cells protect them in what's called a stem cell niche. It's like a biological vault. The mutations don't accumulate or change over time. They just sit there, stable, for 20, 30, 40 years.

Inventor

That contradicts what people thought about older fathers having riskier sperm.

Model

Completely. The old theory was that sperm mutations pile up with age, like damage accumulating on a car. But when they compared young men and old men, the mutations were the same. The risk doesn't increase. It was always there.

Inventor

If one in 15 men carries these mutations, and they can cause autism or heart disease, why isn't this already a major screening issue?

Model

Because until now, there was no reliable way to detect them. The mutations are present in only a small fraction of cells in each ejaculate. You need to sequence sperm hundreds of times and use machine learning to spot them. That's expensive and new. The researchers are now working with fertility clinics to see if screening becomes feasible.

Inventor

So the next step is prevention?

Model

That's the hope. If you can identify which men carry these mutations before they have children, you might be able to prevent disease. But that raises other questions—about who gets tested, what people do with that information, whether it becomes routine or only for certain families.

Fale Conosco FAQ